Tactus AI Unveils Humanoid Lab Assistant at ADLM 2026
Tactus AI debuted Elsie, an autonomous humanoid lab assistant designed to operate existing laboratory instruments using validated procedures, at the 2026 ADLM meeting, according to the company.
Tactus AI debuted Elsie, an autonomous humanoid lab assistant designed to operate existing laboratory instruments using validated procedures, at the 2026 ADLM meeting, according to the company.
As Cyclospora infections surge in the US, laboratories face increased pressure to quickly differentiate cases, with the CDC reporting 1,947 confirmed infections and 98 hospitalizations across nine states as of July 24.
Ibex Medical Analytics has received IVDR certification for its breast cancer diagnostic tools, completing regulatory approval for ER, PR, and Ki67 tests, according to a company press release.
Revvity is developing the T-SPOT A201, an automated platform for latent tuberculosis testing in high-volume labs, with planned launch in 2027 pending regulatory approval.
Researchers report that inherited CDK12 gene variants may increase risk for early, aggressive prostate cancer, suggesting inclusion of CDK12 in hereditary screening panels could improve risk identification in men.